Bryant, Kirsten L. http://orcid.org/0000-0003-4026-0942
Stalnecker, Clint A. http://orcid.org/0000-0002-0570-4416
Zeitouni, Daniel
Klomp, Jennifer E.
Peng, Sen
Tikunov, Andrey P.
Gunda, Venugopal
Pierobon, Mariaelena
Waters, Andrew M. http://orcid.org/0000-0002-6058-5878
George, Samuel D.
Tomar, Garima
Papke, Björn http://orcid.org/0000-0001-8156-7508
Hobbs, G. Aaron http://orcid.org/0000-0002-4751-9681
Yan, Liang
Hayes, Tikvah K.
Diehl, J. Nathaniel
Goode, Gennifer D.
Chaika, Nina V.
Wang, Yingxue
Zhang, Guo-Fang
Witkiewicz, Agnieszka K.
Knudsen, Erik S.
Petricoin, Emanuel F. III
Singh, Pankaj K.
Macdonald, Jeffrey M.
Tran, Nhan L.
Lyssiotis, Costas A. http://orcid.org/0000-0001-9309-6141
Ying, Haoqiang
Kimmelman, Alec C.
Cox, Adrienne D.
Der, Channing J. http://orcid.org/0000-0002-7751-2747
Article History
Received: 18 June 2018
Accepted: 17 January 2019
First Online: 4 March 2019
Change Date: 1 June 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: C.J.D. is on the Scientific Advisory Board of Mirati Therapeutics. A.C.K. has financial interests in Vescor Therapeutics, LLC. A.C.K. is an inventor on patents pertaining to KRAS-regulated metabolic pathways, redox control pathways in pancreatic cancer, targeting GOT1 as a therapeutic approach, and the autophagic control of iron metabolism. A.C.K. is on the Scientific Advisory Board of Cornerstone/Rafael Pharmaceuticals.